Ye Chen

Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial

Xiangyu Gao, Nong Xu, Ziyu Li et al. · The Lancet Oncology · 2023 · 197 citations

Pharmacy, Oncology, Pharmacology +16

First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial

Lin Shen, Yanqiao Zhang, Ziyu Li et al. · Nature Medicine · 2025 · 81 citations

Medicine, Oncology, Pharmacology +11

Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trial

Xiangyu Gao, Ke Ji, Yongning Jia et al. · Nature Medicine · 2024 · 45 citations

Medicine, Oncology, Chemotherapy +12

Circular RNA EIF3I promotes papillary thyroid cancer progression by interacting with AUF1 to increase Cyclin D1 production

Xuelin Yao, Hanyuan Liu, Zhen Wang et al. · Oncogene · 2023 · 19 citations

Medicine, Molecular Biology, Oncology +16